Hepatic protection by glycyrrhizin and inhibition of iNOS expression in concanavalin A-induced liver injury in mice

Inflammation Research

Volumn 58, Issue 9, 2009, Pages 593-599

  Tsuruoka, Noriko ^a   Abe, Kazuki ^a   Wake, Kenjirou ^b   Takata, Masaru ^a   Hatta, Akira ^a   Sato, Tositugu ^a   Inoue, Hideo ^a  

^a Minophagen Pharmaceutical Co   (Japan)

^b Minophagen Pharmaceutical Co Ltd   (Japan)

Author keywords

Concanavalin A liver injury; Glycyrrhizin; Hepatic protection; Inducible nitric oxide synthase

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CONCANAVALIN A; GLYCYRRHIZIC ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; GLYCYRRHIZA; HISTOPATHOLOGY; LIVER CELL; LIVER INJURY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; WESTERN BLOTTING;

ALANINE TRANSAMINASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; ASPARTATE AMINOTRANSFERASES; CONCANAVALIN A; DRUG-INDUCED LIVER INJURY; GLYCYRRHIZIC ACID; HUMANS; LIVER; MALE; MICE; MICE, INBRED BALB C; NITRIC OXIDE SYNTHASE TYPE II; T-LYMPHOCYTES;

EID: 68449099405     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-009-0024-8     Document Type: Article

References (32)

1. M Yoshikawa Y Matsui H Kawamoto N Umemoto K Oku M Koizumi J Yamao S Kuriyama H Nakano N Hozumi S Ishizaka H Fukui 1997 Effects of glycyrrhizin on immune-mediated cytotoxicity J Gastroenterol Hepatol 12 243 248
2. T Okamoto T Kanda 1999 Glycyrrhizin protects mice from concanavalin A-induced hepatitis without affecting cytokine expression Int J Mol Med 4 149 152
3. T Okamoto 2000 The protective effect of glycyrrhizin on anti-Fas antibody-induced hepatitis in mice Eur J Pharmacol 387 229 232 (Pubitemid 30067820)
4. M Kimura H Inoue K Hirabayashi H Natsume M Ogihara 2001 Glycyrrhizin and some analogues induce growth of primary cultured adult rat hepatocytes via epidermal growth factor receptors Eur J Pharmacol 431 151 161
5. M Kimura T Moro H Motegi H Maruyama M Sekine H Okamoto H Inoue T Sato M Ogihara 2008 In vivo glycyrrhizin accelerates liver regeneration and rapidly lowers serum transaminase activities in 70% partially hepatectomized rats Eur J Pharmacol 579 357 364
6. J Yin D Li W Hu Q Meng 2008 Effects of glycyrrhizic acid on cocklebur-induced hepatotoxicity in rat and human hepatocytes Phytother Res 22 395 400
7. B Tang H Qiao F Meng X Sun 2007 Glycyrrhizin attenuates endotoxin-induced acute liver injury after partial hepatectomy in rats Braz J Med Biol Res 40 1637 1646
8. T Yoshida K Abe T Ikeda T Matsushita K Wake T Sato T Sato H Inoue 2007 Inhibitory effect of glycyrrhizin on lipopolysaccharide and d-galactosamine- induced mouse liver injury Eur J Pharmacol 576 136 142
9. K Abe T Ikeda K Wake T Sato T Sato H Inoue 2008 Glycyrrhizin privents of lipopolysaccharide/d-galactosamine-induced liver injury through down-regulation of matrix metalloproteinase-9 in mice J Pharm Pharmacol 60 91 97
10. S Iino T Tango T Matsushima G Toda K Miyake K Hino H Kumada K Yasuda T Kuroki C Hirayama H Suzuki 2001 Therapeutic effects of stronger neo-minophagen C at different doses on chronic hepatitis and liver cirrhosis Hepatol Res 19 31 40
11. Y Arase K Ikeda N Murashima K Chayama A Tsubota I Koida Y Suzuki S Saitoh M Kobayashi H Kumada 1997 The long term efficacy of glycyrrhizin in chronic hepatitis C patients Cancer 79 1494 1500
12. M Ikeda S Fujiyama M Tanaka M Sata T Ide H Yatsuhashi H Watanabe 2006 Clinical features of hepatocellular carcinoma that occur after sustained virological response to interferon for chronic hepatitis C J Gastroenterol Hepatol 21 122 128
13. I Hidaka K Hino M Korenaga T Gondo S Nishina M Ando M Okuda I Sakaida 2007 Stronger Neo-Minophagen C, a glycyrrhizin-containing preparation, protects liver against carbon tetrachloride-induced oxidative stress in transgenic mice expressing the hepatitis C virus polyprotein Liver Int 27 845 853
14. TG van Rossum AG Vulto WC Hop SW Schalm 1999 Pharmacokinetics of intravenous glycyrrhizin after single and multiple doses in patients with chronic hepatitis C infection Clin Ther 21 2080 2090
15. TG van Rossum AG Vulto WC Hop SW Schalm 2001 Glycyrrhizin-induced reduction of ALT in European patients with chronic hepatitis C Am J Gastroenterol 96 2432 2437
16. G Tiegs J Hentschel A Wendel 1992 A T cell-dependent experimental liver injury in mice inducible by concanavalin A J Clin Invest 90 196 203
17. G Sass S Heinlein A Agli R Bang J Schümann G Tiegs 2002 Cytokine expression in three mouse models of experimental hepatitis Cytokine 19 115 120
18. B Jaruga F Hong WH Kim B Gao 2004 IFN-gamma/STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1 Am J Physiol Gastrointest Liver Physiol 287 G1044 G1052
19. S Fujikura H Mizuhara Y Miyazawa H Fujiwara K Kaneda 1996 Kinetics and localization of lymphoblasts that proliferate in the mutine liver after Concanavalin A administration Biomed Res 17 129 139
20. JS, Beckman WH Koppenol 1996 Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly Am J Physiol 271 C1424 37
21. B Halliwell 1997 What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? FEBS Lett 411 157 160
22. KS, Christopherson DS Bredt 1997 Nitric oxide in excitable tissues: physiological roles and diseases J Clin Invest 100 2424 29
23. DG Harrison 1997 Cellular and molecular mechanisms of endothelial cell dysfunction J Clin Invest 100 2153 57
24. G Sass K Koerber R Bang H Guehring G Tiegs 2001 Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice J Clin Invest 107 439 447
25. Y Ito Edward R Abril Nancy W Bethea Robert S [tmp] McCuskey 2004 Role of nitric oxide in hepatic microvascular injury elicited by acetaminophen in mice Am J Physiol Gastrointest Liver Physiol 286 G60 G67
26. XL Ma YH Li JX Gao J Li L Guo CZ Wu 2008 Expression of inducible nitric oxide synthase in the liver is under the control of nuclear factor kappa B in concanavalin A-induced hepatitis J Gastroenterol Hepatol 23 e231 e235
27. K Ohuchi Y Kamada L Levine S Tsurufuji 1981 Glycyrrhizin inhibits prostaglandin E2 production by activated peritoneal macrophages from rats Prostaglandins Med 7 457 463
28. E Okimasu Y Moromizato S Watanabe J Sasaki N Shiraishi YM Morimoto M Miyahara K Utsumi 1983 Inhibition of phospholipase A2 and platelet aggregation by glycyrrhizin, an antiinflammation drug Acta Med Okayama 37 385 391
29. C Feng H Wang C Yao J Zhang Z Tian 2007 Diammonium glycyrrhizinate, a component of traditional Chinese medicine Gan-Cao, prevents murine T-cell-mediated fulminant hepatitis in IL-10- and IL-6-dependent manners Int Immunopharmacol 7 1292 1298
30. M Abe F Akbar A Hasebe N Horiike M Onji 2003 Glycyrrhizin enhances interleukin-10 production by liver dendritic cells in mice with hepatitis J Gastroenterol 38 962 967
31. CH Lee SW Park YS Kim SS Kang JA Kim SH Lee SM Lee 2007 Protective mechanism of glycyrrhizin on acute liver injury induced by carbon tetrachloride in mice Biol Pharm Bull 30 1898 1904
32. JY Wang JS Guo H Li SL Liu MA Zern 1998 Inhibitory effect of glycyrrhizin on NF-kappaB binding activity in CCl4- plus ethanol-induced liver cirrhosis in rats Liver 18 180 185